ciprofloxacin Otic Suspension
- RxCUI
- 1739996
- RxNorm name
- ciprofloxacin Otic Suspension
- Term type
- SCDF
- Status
- Obsolete
- Updated
- 2026-11-04 11:29:53
RxNorm Status History#
- Status
- Obsolete
- Source
- RXNORM
- Current
- NO
- Release start
- 042016
- Active start
- 042016
- Active end
- 042026
- Multiple ingredient
- NO
- Branded
- NO
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Otic Suspension | 316974 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| ciprofloxacin | 2551 |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | S03AA | Antiinfectives | ATC1-4 | ciprofloxacin | |
| ATC | S02AA | Antiinfectives | ATC1-4 | ciprofloxacin | |
| ATC | S01AE | Fluoroquinolones | ATC1-4 | ciprofloxacin | |
| ATC | J01MA | Fluoroquinolones | ATC1-4 | ciprofloxacin | |
| FDASPL | D024841 | Fluoroquinolones | CHEM | has_chemical_structure | ciprofloxacin |
| FDASPL | N0000193223 | Fluoroquinolone Antibacterial | EPC | has_epc | ciprofloxacin |
| FDASPL | N0000182138 | Cytochrome P450 1A2 Inhibitors | MOA | has_moa | ciprofloxacin |
| MEDRT | D002939 | Ciprofloxacin | CHEM | has_ingredient | ciprofloxacin |
| MEDRT | D003000 | Clonidine | CHEM | ci_chemclass | ciprofloxacin |
| MEDRT | D015363 | Quinolones | CHEM | ci_chemclass | ciprofloxacin |
| MEDRT | D000881 | Anthrax | DISEASE | may_treat | ciprofloxacin |
| MEDRT | D001170 | Arthritis, Infectious | DISEASE | may_treat | ciprofloxacin |
| MEDRT | D001442 | Bacteroides Infections | DISEASE | may_treat | ciprofloxacin |
| MEDRT | D002169 | Campylobacter Infections | DISEASE | may_treat | ciprofloxacin |
| MEDRT | D003234 | Conjunctivitis, Bacterial | DISEASE | may_treat | ciprofloxacin |
| MEDRT | D003556 | Cystitis | DISEASE | may_treat | ciprofloxacin |
| MEDRT | D003967 | Diarrhea | DISEASE | may_treat | ciprofloxacin |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | ciprofloxacin |
| MEDRT | D004403 | Dysentery | DISEASE | may_treat | ciprofloxacin |
| MEDRT | D004927 | Escherichia coli Infections | DISEASE | may_treat | ciprofloxacin |
| MEDRT | D005334 | Fever | DISEASE | may_treat | ciprofloxacin |
| MEDRT | D006069 | Gonorrhea | DISEASE | may_treat | ciprofloxacin |
| MEDRT | D006192 | Haemophilus Infections | DISEASE | may_treat | ciprofloxacin |
| MEDRT | D059413 | Intraabdominal Infections | DISEASE | may_treat | ciprofloxacin |
| MEDRT | D007710 | Klebsiella Infections | DISEASE | may_treat | ciprofloxacin |
| MEDRT | D009503 | Neutropenia | DISEASE | may_treat | ciprofloxacin |
| MEDRT | D010019 | Osteomyelitis | DISEASE | may_treat | ciprofloxacin |
| MEDRT | D010032 | Otitis Externa | DISEASE | may_treat | ciprofloxacin |
| MEDRT | D011472 | Prostatitis | DISEASE | may_treat | ciprofloxacin |
| MEDRT | D011512 | Proteus Infections | DISEASE | may_treat | ciprofloxacin |
| MEDRT | D011552 | Pseudomonas Infections | DISEASE | may_treat | ciprofloxacin |
| MEDRT | D011704 | Pyelonephritis | DISEASE | may_treat | ciprofloxacin |
| MEDRT | D012852 | Sinusitis | DISEASE | may_treat | ciprofloxacin |
| MEDRT | D017192 | Skin Diseases, Bacterial | DISEASE | may_treat | ciprofloxacin |
| MEDRT | D013203 | Staphylococcal Infections | DISEASE | may_treat | ciprofloxacin |
| MEDRT | D014435 | Typhoid Fever | DISEASE | may_treat | ciprofloxacin |
| MEDRT | D014552 | Urinary Tract Infections | DISEASE | may_treat | ciprofloxacin |
| MEDRT | N0000020086 | DNA Gyrase Inhibitors | MOA | has_moa | ciprofloxacin |
| MEDRT | N0000020087 | Topoisomerase 4 Inhibitors | MOA | has_moa | ciprofloxacin |
| MEDRT | N0000008576 | Decreased DNA Integrity | PE | has_pe | ciprofloxacin |
| MEDRT | N0000008577 | Decreased DNA Replication | PE | has_pe | ciprofloxacin |
| MEDRT | N0000009011 | Decreased Transcription to RNA | PE | has_pe | ciprofloxacin |
| MEDRT | N0000009531 | Increased Protein Breakdown | PE | has_pe | ciprofloxacin |